Literature DB >> 16168532

Dupuytren's contracture: an update of biomolecular aspects and therapeutic perspectives.

A Cordova1, M Tripoli, B Corradino, P Napoli, F Moschella.   

Abstract

The so-called fibrogenic cytokines, able to induce the growth of fibroblasts and their differentiation into myofibroblasts and to stimulate their production of extracellular matrix, are involved in the genesis of Dupuytren's contracture. Although many studies have been made of biomolecular aspects of palmar fibromatosis, practical applications from them are still far from imminent because of the real difficulty of blocking their action in vivo, even in a chronic, progressive lesion such as Dupuytren's disease. Consequently, surgical excision of the palmar fascia still remains the treatment of choice.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16168532     DOI: 10.1016/j.jhsb.2005.07.002

Source DB:  PubMed          Journal:  J Hand Surg Br        ISSN: 0266-7681


  9 in total

Review 1.  The fascia of the limbs and back--a review.

Authors:  Mike Benjamin
Journal:  J Anat       Date:  2009-01       Impact factor: 2.610

2.  Role of the HLA System in the Pathogenesis of Dupuytren's Disease.

Authors:  Sara McCarty; Farhatullah Syed; Ardeshir Bayat
Journal:  Hand (N Y)       Date:  2010-02-09

3.  Update on the role of molecular factors and fibroblasts in the pathogenesis of Dupuytren's disease.

Authors:  Massimiliano Tripoli; Adriana Cordova; Francesco Moschella
Journal:  J Cell Commun Signal       Date:  2016-06-07       Impact factor: 5.782

4.  Beta-catenin overexpression in Dupuytren's disease is unrelated to disease recurrence.

Authors:  Ilse Degreef; Luc De Smet; Raf Sciot; Jean-Jacques Cassiman; Sabine Tejpar
Journal:  Clin Orthop Relat Res       Date:  2008-10-29       Impact factor: 4.176

Review 5.  Dupuytren's: a systems biology disease.

Authors:  Samrina Rehman; Royston Goodacre; Philip J Day; Ardeshir Bayat; Hans V Westerhoff
Journal:  Arthritis Res Ther       Date:  2011-09-12       Impact factor: 5.156

6.  Splinting after contracture release for Dupuytren's contracture (SCoRD): protocol of a pragmatic, multi-centre, randomized controlled trial.

Authors:  Christina Jerosch-Herold; Lee Shepstone; Adrian J Chojnowski; Debbie Larson
Journal:  BMC Musculoskelet Disord       Date:  2008-04-30       Impact factor: 2.362

7.  The roles of Tenascin C and Fibronectin 1 in adhesive capsulitis: a pilot gene expression study.

Authors:  Carina Cohen; Mariana Ferreira Leal; Paulo Santoro Belangero; Eduardo Antônio Figueiredo; Marília Cardoso Smith; Carlos Vicente Andreoli; Alberto de Castro Pochini; Moises Cohen; Benno Ejnisman; Flávio Faloppa
Journal:  Clinics (Sao Paulo)       Date:  2016-07       Impact factor: 2.365

8.  Treatment of dupuytren disease with injectable collagenase in a veteran population: a case series at the department of veterans affairs new jersey health care system.

Authors:  Aditya Sood; Paul J Therattil; Angie M Paik; Mary F Simpson; Edward S Lee
Journal:  Eplasty       Date:  2014-03-27

Review 9.  Basics of Radiation Biology When Treating Hyperproliferative Benign Diseases.

Authors:  Franz Rödel; Claudia Fournier; Julia Wiedemann; Felicitas Merz; Udo S Gaipl; Benjamin Frey; Ludwig Keilholz; M Heinrich Seegenschmiedt; Claus Rödel; Stephanie Hehlgans
Journal:  Front Immunol       Date:  2017-05-03       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.